Actively Recruiting
The Effect of Cord Blood Serum Eyes Drops Administer in Patients With Severe Keratopathy Related to EGFR-I Treatment
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-02-17
10
Participants Needed
1
Research Sites
120 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study aim to evaluate the efficacy of cord blood eye drops in the healing of the damaged corneal epithelium.
CONDITIONS
Official Title
The Effect of Cord Blood Serum Eyes Drops Administer in Patients With Severe Keratopathy Related to EGFR-I Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 18 years
- Patients with advanced cancer who have an EGFR mutation and need treatment with anti-EGFR drugs
- Signed informed consent to participate in the study
You will not qualify if you...
- Patients unable to store or administer the cord blood serum eye drops independently or with caregiver assistance
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy, 40138
Actively Recruiting
Research Team
L
Luigi Fontana, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here